Literature DB >> 25355453

Tissue microstructural changes in dementia with Lewy bodies revealed by quantitative MRI.

Li Su1, Andrew M Blamire, Rosie Watson, Jiabao He, Benjamin Aribisala, John T O'Brien.   

Abstract

We aimed to characterize dementia with Lewy bodies (DLB) by the quantitative MRI parameters of longitudinal relaxation time (qT1) and transverse relaxation time (qT2). These parameters reflect potential pathological changes in tissue microstructures, which may be detectable noninvasively in brain areas without evident atrophy, so may have potential value in revealing the early neuropathological changes in DLB. We conducted a cross-sectional study of subjects with DLB (N = 35) and similarly aged control participants (N = 35). All subjects underwent a detailed clinical and neuropsychological assessment and structural and quantitative 3T MRI. Quantitative MRI maps were obtained using relaxation time mapping methods. Statistical analysis was performed on gray matter qT1 and qT2 values. We found significant alterations of quantitative parameters in DLB compared to controls. In particular, qT1 decreases in bilateral temporal lobes, right parietal lobes, basal ganglia including left putamen, left caudate nucleus and left amygdala, and left hippocampus/parahippocampus; qT2 decreases in left putamen and increases in left precuneus. These regions showed only partial overlap with areas where grey matter loss was found, making atrophy an unlikely explanation for our results. Our findings support that DLB is predominantly associated with changes in posterior regions, such as visual association areas, and subcortical structures, and that qT1 and qT2 measurement can detect subtle changes not seen on structural volumetric imaging. Hence, quantitative MRI may compliment other imaging techniques in detecting early changes in DLB and in understanding neurobiological changes associated with the disorder.

Entities:  

Mesh:

Year:  2014        PMID: 25355453     DOI: 10.1007/s00415-014-7541-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  36 in total

1.  Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.

Authors:  M A Piggott; E F Marshall; N Thomas; S Lloyd; J A Court; E Jaros; D Burn; M Johnson; R H Perry; I G McKeith; C Ballard; E K Perry
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

2.  Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study.

Authors:  Rosie Watson; John T O'Brien; Robert Barber; Andrew M Blamire
Journal:  Int Psychogeriatr       Date:  2011-11-30       Impact factor: 3.878

Review 3.  Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology.

Authors:  Satoshi Minoshima; Norman L Foster; Eric C Petrie; Roger L Albin; Kirk A Frey; David E Kuhl
Journal:  J Geriatr Psychiatry Neurol       Date:  2002       Impact factor: 2.680

4.  Comparative study of standard space and real space analysis of quantitative MR brain data.

Authors:  Benjamin S Aribisala; Jiabao He; Andrew M Blamire
Journal:  J Magn Reson Imaging       Date:  2011-06       Impact factor: 4.813

5.  Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry.

Authors:  E J Burton; G Karas; S M Paling; R Barber; E D Williams; C G Ballard; I G McKeith; P Scheltens; F Barkhof; J T O'Brien
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

6.  Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale.

Authors:  R S Bucks; D L Ashworth; G K Wilcock; K Siegfried
Journal:  Age Ageing       Date:  1996-03       Impact factor: 10.668

7.  Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.

Authors:  Jennifer L Whitwell; Stephen D Weigand; Maria M Shiung; Bradley F Boeve; Tanis J Ferman; Glenn E Smith; David S Knopman; Ronald C Petersen; Eduardo E Benarroch; Keith A Josephs; Clifford R Jack
Journal:  Brain       Date:  2007-01-31       Impact factor: 13.501

8.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

9.  Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.

Authors:  Mona K Beyer; Jan P Larsen; Dag Aarsland
Journal:  Neurology       Date:  2007-08-21       Impact factor: 9.910

Review 10.  FSL.

Authors:  Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

View more
  4 in total

Review 1.  Dementia with Lewy bodies - from scientific knowledge to clinical insights.

Authors:  Nikitas A Arnaoutoglou; John T O'Brien; Benjamin R Underwood
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

2.  Quantitative measurement of macromolecular tissue properties in white and gray matter in healthy aging and amnestic MCI.

Authors:  Elveda Gozdas; Hannah Fingerhut; Hua Wu; Jennifer L Bruno; Lauren Dacorro; Booil Jo; Ruth O'Hara; Allan L Reiss; S M Hadi Hosseini
Journal:  Neuroimage       Date:  2021-05-15       Impact factor: 7.400

3.  Can MRI T1 be used to detect early changes in 5xFAD Alzheimer's mouse brain?

Authors:  Nicholas G Spencer; David P Lovell; Kay Elderfield; Brian Austen; Franklyn A Howe
Journal:  MAGMA       Date:  2016-10-26       Impact factor: 2.310

4.  Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.

Authors:  L Su; A M Blamire; R Watson; J He; L Hayes; J T O'Brien
Journal:  Transl Psychiatry       Date:  2016-08-30       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.